Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thermo Electron

This article was originally published in The Gray Sheet

Executive Summary

Company will repurchase up to $50 mil. of its own securities and those of its publicly held subsidiaries over the next 12 months, Thermo Electron reports May 26. Under authorization of the board of directors, the firm will "repurchase these securities when they are available at prices the company considers attractive, or to maintain the required ownership of such subsidiaries for accounting and/or tax consolidation." Thermo Electron also is allowed under previous board authorization to repurchase roughly $26 mil. of its own securities or those of its subsidiaries through January 1999
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT010127

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel